Description: Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal, acid removal, 3-ketal, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
Home Page: www.sitobiotech.com
Renxin industrial park
Heze,
China
Phone:
86 53 0226 3536
Officers
| Name | Title |
|---|---|
| Mr. Qi Mi | Chairman & GM |
| Mr. Fuwen Li | Chief Financial Officer |
| Ms. Qing Zhi Kong | Deputy Gen. Mang. |
| Qingli Zeng | Securities Representative |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 53.4884 |
| Price-to-Book MRQ: | 1.6549 |
| Price-to-Sales TTM: | 2.3884 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1140 |